As of 2025-06-20, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (2,085.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 232.00 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -999.1%.
The range of the Relative Valuation is (2,166.32) - (2,104.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.0x - 30.2x | 28.2x |
| Forward P/E multiples | 25.2x - 27.2x | 25.8x |
| Fair Price | (2,166.32) - (2,104.51) | (2,085.97) |
| Upside | -1033.8% - -1007.1% | -999.1% |
| Date | P/E |
| 2025-06-18 | -3.00 |
| 2025-06-17 | -2.98 |
| 2025-06-16 | -3.00 |
| 2025-06-13 | -2.94 |
| 2025-06-12 | -3.01 |
| 2025-06-11 | -2.98 |
| 2025-06-10 | -2.98 |
| 2025-06-09 | -2.92 |
| 2025-06-06 | -2.84 |
| 2025-06-05 | -2.84 |
| 2025-06-04 | -2.87 |
| 2025-06-03 | -2.85 |
| 2025-06-02 | -2.80 |
| 2025-05-30 | -2.94 |
| 2025-05-29 | -2.95 |
| 2025-05-28 | -2.97 |
| 2025-05-27 | -2.98 |
| 2025-05-23 | -2.90 |
| 2025-05-22 | -2.94 |
| 2025-05-21 | -2.95 |
| 2025-05-20 | -3.20 |
| 2025-05-19 | -3.22 |
| 2025-05-16 | -3.22 |
| 2025-05-15 | -3.15 |
| 2025-05-14 | -3.07 |
| 2025-05-13 | -3.28 |
| 2025-05-12 | -3.32 |
| 2025-05-09 | -3.09 |
| 2025-05-08 | -3.12 |
| 2025-05-07 | -3.01 |
| 2025-05-06 | -3.00 |
| 2025-05-05 | -3.11 |
| 2025-05-02 | -3.06 |
| 2025-05-01 | -3.11 |
| 2025-04-30 | -3.16 |
| 2025-04-29 | -3.14 |
| 2025-04-28 | -3.11 |
| 2025-04-25 | -3.14 |
| 2025-04-24 | -3.23 |
| 2025-04-23 | -3.22 |
| 2025-04-22 | -3.17 |
| 2025-04-21 | -3.07 |
| 2025-04-17 | -3.08 |
| 2025-04-16 | -3.17 |
| 2025-04-15 | -3.17 |
| 2025-04-14 | -3.23 |
| 2025-04-11 | -3.18 |
| 2025-04-10 | -3.01 |
| 2025-04-09 | -3.23 |
| 2025-04-08 | -2.85 |